Incretins in fibrocalculous pancreatic diabetes: A unique subtype of pancreatogenic diabetes.

Ipsita GhoshPradip MukhopadhyayKshaunish DasBeatrice Anne MSamim Ali MondalMadhurima BasuTitli NargisKaushik PanditPartha ChakrabartiSujoy Ghosh

Published in: Journal of diabetes (2020)

In FCPD, basal C-peptide and glucagon are low, and glucagon does not increase after glucose load. GLP-1, but not GIP, in FCPD increases 1.5 to 2 times as compared with T2DM and controls (fasting and post glucose) without differences in DPP-IV.

Keyphrases

blood glucose
glycemic control
type diabetes
cardiovascular disease
insulin resistance
weight loss
adipose tissue
skeletal muscle